Arun Narayan – Chairman, Value Added Medicines Group, Medicines for Europe

31 January 2020

Arun Narayan is the Chairman of the Value Added Medicines […]

Biosimilar Uptake in Europe: Big Challenges; Bigger Rewards

16 January 2020

Since the first treatment was approved in 2006, Europe has […]

Biosimilars ‒ Policy failings that deny savings to countries that need it most

21 November 2019

Future and Challenges of the Pharmaceutical Industry

14 November 2019

Interview: Adrian van den Hoven, Director General of Medicines for Europe

8 January 2019

Over the last ten years, generic medicines have increased access […]

SPC manufacturing waiver is good news for Europe

19 September 2018

An SPC manufacturing waiver should be extremely beneficial for Europe […]

Analysis of the proposal for a regulation of a manufacturing exception related to the SPC and aimed to make the European industry competitive

13 September 2018

Andriukaitis: SPC manufacturing waiver does not damage pharma innovation

12 June 2018

Generics driving pharmerging market growth? ‘There is still opportunity for EU’ says Medicines for Europe

22 May 2018

Up to 25,000 pharma jobs if EU alters patent rules

21 May 2018